Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jabra Enhance is a prominent provider of hearing health solutions, specializing in the direct-to-consumer delivery of medical-grade hearing aids and audiological care. Formerly known as Lively, the company was acquired by GN Group to bolster its position in the emerging over-the-counter and telehealth hearing aid markets. Jabra Enhance offers a streamlined digital platform where customers can take hearing tests, purchase devices, and receive remote adjustments from licensed audiologists. Their product lineup includes the Jabra Enhance Select series, which features advanced noise reduction and Bluetooth connectivity. By leveraging a telehealth-first model, the company aims to reduce the barriers of cost and clinic visits associated with traditional hearing care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jabra Enhance.